Researchers

KUDO Masatoshi

KUDO Masatoshi
Professor/Senior Staff/Vice President
Faculty Department of Medicine / Graduate School of Medical Sciences
Researchmap https://researchmap.jp/m-kudo

Education and Career

Academic & Professional Experience

  • Apr. 1999 - Today , Kindai University Faculty of Medicine Professor and Chairman

Research Activities

Research Areas

  • Life sciences , Medical systems
  • Life sciences , Gastroenterology
  • Life sciences , Tumor diagnostics and therapeutics

Research Interests

Hepatocellular carcinoma, 肝腫瘍の画像診断, Conrast-ehnaced ultrasonogaraphy, EOB-MRI, Radiofreuqency ablation (RFA), Transarterial chemoembolization (TACE), 肝動注化学療法, Molecular targeted therapy, 血管新生阻害治療, Immunotherapy, Immune checkpoint inhibitor

Published Papers

  1. Usefulness of the Lymphocyte-to-Monocyte Ratio in Predicting Prognosis in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab.
    Emi Tanaka; Toshifumi Tada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Takashi Nishimura; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Takanori Matsuura; Yoshihide Ueda; Tomomitsu Matono; Soo Ki Kim; Hideko Ohama; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Jumpei Okamura; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada
    Oncology  , 1-26, 3, Aug. 2026 
  2. Baseline DCP May Modify Response to Atezolizumab-Bevacizumab Versus Durvalumab-Tremelimumab in Unresectable HCC.
    Kazunari Tanaka; Kunihiko Tsuji; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Takashi Nishimura; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Fujimasa Tada; Hideko Ohama; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada
    Liver international : official journal of the International Association for the Study of the Liver  46  (8)  , e70803-, Aug. 2026 
  3. Simplified BALAD (BALAD-S) Score as a Guide for First-Line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma.
    Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Takashi Nishimura; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Hironori Tanaka; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Yoshihide Ueda; Soo Ki Kim; Shintaro Takaki; Fujimasa Tada; Hideko Ohama; Shinichiro Nakamura; Takanori Matsuura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Jumpei Okamura; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Tamami Abe; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada
    Hepatology research : the official journal of the Japan Society of Hepatology  16, Jul. 2026 

MORE

Books etc

  1. 令和4年度改定薬学教育モデル・コア・カリキュラム準拠 疾患で学ぶ 病態・薬物治療 , 米田頼晃; 工藤正俊 , 炎症性腸疾患・大腸癌 , アークメディア, 東京 , 2025
  2. デュルバルマブ・トレメリムマブ併用療法による肝細胞癌治療 , 工藤正俊 , デュルバルマブ・トレメリムマブ併用療法の登場による肝細胞癌治療の今後の展開 , アークメディア, 東京 , Jan. 2025
  3. デュルバルマブ・トレメリムマブ併用療法による肝細胞癌治療 , 工藤正俊 , STRIDEレジメンによるsuper responderとその予測 , アークメディア, 東京 , Jan. 2025

MORE

Conference Activities & Talks

  1. 座長: 特別講演「肝疾患新時代に求められる肝疾患対策～B型肝炎から脂肪肝まで～」 , 工藤正俊 , 第10回関西肝疾患フォーラム , 8, Aug. 2026
  2. 特別講演「CTLA-4が切り拓く進行肝癌の治療変革」 , 工藤正俊 , HCC Premier Summit in Summer , 3, Aug. 2026
  3. 特別講演「肝細胞癌薬物療法のCutting edge」 , 工藤 正俊 , Meet the Expert on Hepatocellular Carcinoma , 1, Aug. 2026

MORE

MISC

  1. A multicenter, phase 2 study of atezolizumab plus bevacizumab (atezo plus bev) combination therapy in patients with unresectable hepatocellular carcinoma (HCC) and Child-Pugh class B cirrhosis: CHALLENGE trial final results. , Masafumi Ikeda; Takeshi Terashima; Tatsuya Yamashita; Takuji Okusaka; Hiroshi Imaoka; Tomokazu Kawaoka; Satoshi Kobayashi; Sadahisa Ogasawara; Atsushi Hiraoka; Masahito Nakano; Fumio Nagashima; Rie Sugimoto; Michihisa Moriguchi; Yoshitaka Inaba; Satoru Shinoda; Makoto Ueno; Naoya Kato; Masatoshi Kudo; Junji Furuse; Hiroaki Nagano , JOURNAL OF CLINICAL ONCOLOGY , 43 , 4_SUPPL , Feb. 2025
  2. 複合免疫療法時代のシークエンシャル治療-HERITAGE試験から- , 淺岡良成; 淺岡良成; 建石良介; 山田康秀; 國土貴嗣; 斎藤明子; 長谷川潔; 坂元亨宇; 武冨紹信; 田中真二; 村上卓道; 吉満研吾; 黒崎雅之; 波多野悦朗; 松山裕; 工藤正俊; 國土典宏 , 日本肝がん分子標的治療研究会プログラム・抄録集 , 32nd , 2025
  3. 全国原発性肝癌追跡調査の機械学習により構築された3cm以下3個以下肝細胞癌の根治的治療法(肝切除術/ラジオ波焼灼術)選択を支援するAIアルゴリズム , 國土貴嗣; 山田康秀; 淺岡良成; 建石良介; 壁谷佳典; 鎌田亜美; 吉田澄人; 中村悠馬; 吉満研吾; 矢野博久; 村上卓道; 福本巧; 波多野悦朗; 島田光生; 加藤直也; 飯島尋子; 黒崎雅之; 坂元亨宇; 工藤正俊; 國土典宏 , 日本肝がん分子標的治療研究会プログラム・抄録集 , 32nd , 2025

MORE

Awards & Honors

  1. Apr. 2022, 日本消化器病学会学術賞受賞
  2. Nov. 2021, Highly Cited Researchers 2021 受賞(Clarivate Analytics:臨床医学部門）(日本人2名中1名)
  3. May. 2021, 日本超音波医学会 学会特別賞

MORE

Research Grants & Projects

  1. 日本学術振興会, 科学研究費助成事業, 肝内胆管がんの複合免疫療法抵抗性を規定するエピゲノム制御異常の解明 , 近畿大学
  2. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Evaluation of the current status of exposure and reduction measures in fluoroscopic endoscopic procedures (a nationwide multicenter study) , Kindai University
  3. 日本学術振興会, 科学研究費助成事業, 免疫チェックポイント阻害剤投与に伴う急速な腫瘍増大(HPD)の発症機序の解析 , 近畿大学

MORE